| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Levy Richard S is a Director at Protara Therapeutics, Inc. with holdings across 4 companies. Recent SEC Form 4 filings include 23 buys and 35 sells.
Estimated insider holdings value: $13.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 13, 2025 | MDGL Madrigal Pharmaceuticals, Inc. | Director | Sale+OE | 8,500 | $520.96 | $4,428,197.57 | -2.4% | -6.6% | - | |
| May 14, 2025 | TARA Protara Therapeutics, Inc. | Director | Buy | 20,000 | $3.19 | $63,800.00 | +64.5% | -1.9% | - | |
| Nov 7, 2024 | MDGL Madrigal Pharmaceuticals, Inc. | Director | Sale+OE | 5,000 | $350.00 | $1,750,000.00 | -31.2% | -4.2% | +37.9% | |
| Nov 1, 2024 | MDGL Madrigal Pharmaceuticals, Inc. | Director | Sale+OE | 5,000 | $300.94 | $1,504,703.41 | -9.5% | +5.9% | +31.1% | |
| Apr 1, 2024 | MDGL Madrigal Pharmaceuticals, Inc. | Director | Sale+OE | 11,000 | $257.48 | $2,832,334.60 | -13.0% | +9.2% | +26.7% | |
| Jan 17, 2023 | MDGL Madrigal Pharmaceuticals, Inc. | Director | Sale+OE | 22,489 | $293.15 | $6,592,685.55 | -9.4% | -13.1% | -18.7% | |
| Mar 20, 2020 | KOD Kodiak Sciences Inc. | Director | Buy | 1,000 | $44.33 | $44,330.00 | +400.0% | - | - | |
| Aug 23, 2017 | MDGL Madrigal Pharmaceuticals, Inc. | Director | Buy | 2,000 | $16.12 | $32,235.91 | +6.5% | - | - | |
| Aug 22, 2017 | MDGL Madrigal Pharmaceuticals, Inc. | Director | Buy | 3,550 | $16.12 | $57,209.06 | +19.5% | - | - | |
| Aug 21, 2017 | MDGL Madrigal Pharmaceuticals, Inc. | Director | Buy | 3,550 | $15.88 | $56,358.30 | +18.2% | - | - |